Alphabet partners with Sanofi to launch diabetes joint venture

Alphabet partners with Sanofi to launch diabetes joint venture
French pharmaceutical company Sanofi and Verily Life Sciences, a unit of Google parent Alphabet, have launched a joint venture aimed at creating simple and intelligent diabetes management systems.

Joshua Riff, who was a senior executive at UnitedHealth Group’s health services company Optum, has been appointed as the Chief Executive Officer of Onduo. ‘My experience as a physician and in leading consumer health initiatives has shown me the daily burden of living with diabetes,’ Riff said. ‘From monitoring food intake to testing glucose levels to actively seeking medical care, the challenges both on the physical and mental well-being of a person living with diabetes are incredibly difficult. We want to develop solutions that allow people living with diabetes to focus on the things they love and enjoy in life by providing tools to make dealing with their diabetes less burdensome,’ Riff noted. Alphabet and Sanofi plan to invest about $500 million in the joint venture, according to reports. Read to know more on medicines for diabetes — types, side effects, drug interactions.

Source: IANS

Photo source: Shutterstock

Disclaimer: TheHealthSite.com does not guarantee any specific results as a result of the procedures mentioned here and the results may vary from person to person. The topics in these pages including text, graphics, videos and other material contained on this website are for informational purposes only and not to be substituted for professional medical advice.

Previous Article

1.1 million HIV positive Indians don't get drugs they need

Next Article

Social in autistic people may increase due to an identified drug target